Cereno Scientific AB (publ) (STO:CRNO.B)
6.55
-0.18 (-2.68%)
At close: Feb 9, 2026
Cereno Scientific AB Revenue
Cereno Scientific AB had revenue of 12.48M SEK in the quarter ending September 30, 2025, a decrease of -47.62%. This brings the company's revenue in the last twelve months to 46.66M, down -46.22% year-over-year. In the year 2024, Cereno Scientific AB had annual revenue of 80.90M with 64.18% growth.
Revenue (ttm)
46.66M
Revenue Growth
-46.22%
P/S Ratio
43.78
Revenue / Employee
4.67M
Employees
10
Market Cap
2.04B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 80.90M | 31.63M | 64.18% |
| Dec 31, 2023 | 49.28M | -8.26M | -14.36% |
| Dec 31, 2022 | 57.54M | 12.73M | 28.42% |
| Dec 31, 2021 | 44.81M | 36.58M | 444.85% |
| Dec 31, 2020 | 8.22M | 1.29M | 18.64% |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BioGaia AB | 1.46B |
| EQL Pharma AB | 425.75M |
| Enzymatica AB | 52.73M |
| Cinclus Pharma Holding AB | 48.42M |
| Nanexa AB | 31.92M |
| Orexo AB | 26.00M |
| Moberg Pharma AB | 12.50M |
| Klaria Pharma Holding AB (publ.) | 10.05M |